 |
Prospector
Profile
07.1288
|
| |
| Sentisearch, Inc. |
NAICS |
541710 |
| 1482 East Valley Road
Santa Barbara, CA 93108 |
Description |
Chemicals Research & Dev't. |
| (805) 684-1830 |
Employees |
0 |
|
Revenue |
(mil) |
0.0000 |
| |
Income |
(mil) |
-0.4370 |
| |
Assets |
(mil) |
0.1760 |
| |
Liability |
(mil) |
0.0390 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Sentisearch, Inc. reported a net loss of $68,739 for the three months ended June 30, 2007, more than double the net loss reported during the same period last year of $31,286. For the six months ended June 30, 2007, the Company reported a net loss of $113,070, compared to a net loss of $72,862 during the first half of 2006. The Company's balance sheet showed an accumulated deficit of $974,629 and strained liquidity with $113,046 in total current assets availble to pay $181,068 in total current liabilities.
|
| |
|
Intellectual Property:
On April 10, 2000, the Company entered into a license agreement with The Trustees of Columbia University in the City of New York. The exclusive license agreement provides the Company with worldwide rights to Columbia’s patent applications and other rights in the areas of insect chemosensation and olfaction. In addition to the Columbia License, the Company has certain patent applications relating to nucleic acids and proteins of insect or 83b odorant receptor genes and their uses. The Company believes that the olfaction intellectual property may be of value to non-profit and commercial partners wishing to develop novel, safer and more effective means to control pest insects through molecular manipulation of insect olfaction and taste. [SEC Filing 10-KSB 04-02-07]
|
| |
|
Description:
The Company holds olfaction intellectual property assets of Sentigen Holding Corp. and its subsidiaries.
|
| |
|
Officers:
Joseph K. Pagano (Chair, CEO, Sec. & Dir.); Frederick R. Adler (Dir.); Thomas J. Livelli (Dir.)
|
| |
|
Auditor:
Raich Ende Malter & Co. LLP
|
| |
|
Securities:
Common Stock-Symbol SSRC.OB; OTC BB;
7,694,542 common shares outstanding as of August 6, 2007.
|
| |
| |
| |
| return to main page |
|
|
